Search Ontology:
ChEBI

succinyl-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin

Term ID
CHEBI:52770
Synonyms
  • 4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-3-(4-hydroxyphenyl)-1-[(4-methyl-2-oxochromen-7-yl)amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl] amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-oxobutanoic acid
  • N-(3-carboxypropanoyl)-L-leucyl-L-leucyl-L-valyl-N-(4-methyl-2-oxo-2H-chromen-7-yl)-L-tyrosinamide
  • N-Succinyl-leu-leu-val-tyr-7-amido-4-methylcoumarin
  • S6510_sigma
  • Suc-leu-leu-val-tyr-7-amino-4-methylcoumarin
  • Suc-Leu-Leu-Val-Tyr-AMC
  • Suc-leu-leu-val-tyr-mca
  • Suc-LLVY-AMC
  • Suc-LLVY-mca
  • Succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide
Definition
A tetrapeptide compound with a succinyl group at the N-terminal and a 7-amino-4-methylcoumarin group at the C-terminal.
References
  • Beilstein:6887904
  • CAS:94367-21-2
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
is a type of
has_role
Phenotype
Phenotype resulting from succinyl-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin
Phenotype where environments contain succinyl-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin
Phenotype modified by environments containing succinyl-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin
Human Disease Model